Here is an excerpt from the Seeking Alpha article - vaccine worth BILLIONS!
BTW - does anyone know what the author meant by "5 months development to in-human testing"?
Assuming Generex's Ii-Key vaccine for COVID-19 is safer and more effective than big pharma rivals Moderna, AstraZeneca, and Pfizer, the vaccine could be worth billions. However, realization of this value will first require building a salesforce and marketing engine or a partnership with another big pharma company. Regardless, Generex's rapidly developed (5 months development to in-human testing) and precision vaccines may finally bring it value under the relatively new leadership of Joe Moscato.
Thanks!
https://seekingalpha.com/article/4373034-gene...ompetition
BTW - does anyone know what the author meant by "5 months development to in-human testing"?
Assuming Generex's Ii-Key vaccine for COVID-19 is safer and more effective than big pharma rivals Moderna, AstraZeneca, and Pfizer, the vaccine could be worth billions. However, realization of this value will first require building a salesforce and marketing engine or a partnership with another big pharma company. Regardless, Generex's rapidly developed (5 months development to in-human testing) and precision vaccines may finally bring it value under the relatively new leadership of Joe Moscato.
Thanks!
https://seekingalpha.com/article/4373034-gene...ompetition
